Nomura Asset Management CO LTD Veracyte, Inc. Transaction History

Nomura Asset Management CO LTD

19 transactions

Quarter	Operation	Price Per share	shares change
Q4 2022 Jan 10, 2025	BUY	$15.31 - $29.94 $0 - $0	0 New
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $0 - $0	0 New
Q3 2022 Jan 10, 2025	BUY	$16.58 - $27.9 $0 - $0	0 New
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $0 - $0	0 New
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $0 - $0	0 New
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $0 - $0	0 New
Q2 2022 Jan 10, 2025	BUY	$15.45 - $29.52 $0 - $0	0 New
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $0 - $0	0 New
Q1 2022 Jan 10, 2025	BUY	$21.94 - $42.51 $0 - $0	0 New
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $0 - $0	0 New
Q4 2021 Jan 10, 2025	BUY	$36.09 - $53.79 $0 - $0	0 New
Q4 2021 Feb 01, 2022	BUY	$36.09 - $53.79 $0 - $0	0 New
Q3 2021 Jan 10, 2025	BUY	$35.62 - $52.97 $0 - $0	0 New
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $0 - $0	0 New
Q3 2020 Nov 12, 2020	SELL	$26.73 - $35.67 $0 - $0	0 Closed
Q2 2020 Aug 13, 2020	BUY	$19.49 - $28.11 $0 - $0	0 New
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $0 - $0	0 New
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $0 - $0	0 New
Q3 2019 Nov 13, 2019	BUY	$23.87 - $30.93 $0 - $0	0 New

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.